The

groups of claimants for which FCE information was thought to be useful were claimants with MSDs, claimants with medically unexplained disorders, claimants with complex disorders, which make it difficult to assess the work ability, like fibromyalgia, chronic fatigue syndrome, whiplash, and repetitive strain injury, and claimants with a large discrepancy between objective findings and subjective feelings of ATM/ATR inhibitor disability on one side and claimants with MSDs on the other side. These groups were named by resp. three and six IPs, respectively. Two IPs gave 17DMAG cost arguments in favor of FCE assessment not specifically related to claimant characteristics, like when the question about fitness for one’s own job is at stake. Complementary value and future use Finally, IPs who indicated that FCE information has complementary value also have more often the intention of using

FCE information in future disability claim assessments (P = .01), confirming the hypothesis that a positive judgment about the complementary value of FCE was related to an intention of future use of this information in C188-9 mw disability claim procedures. No relation was found between the answer about the complementary value and the reinforcement of judgment. This implicates that FCE information can reinforce the judgment about the physical work ability without being judged as of complementary value according to IPs. Discussion The aim of this study was to establish

whether FCE information had complementary value for IPs in their judgment of physical work ability. About two-thirds of the IPs affirmed the complementary value of FCE in this context, and stated that it helped to provide a firmer basis for their decisions. Sixty-four percent of the IPs indicated that they intend to include FCE information in future disability claim assessments. In contrast to earlier studies about FCE information in work situations (Gross et al. 2004; Gross and Battié 2004, 2006), this study took disability claim assessments into context. The strength of the study is that FCE information was introduced into the normal routine of disability claim assessments. This means that the IPs’ judgment about the complementary value Uroporphyrinogen III synthase of FCE information was placed in the context of work ability assessment practice; it should be noted, however, that the FCE information did not influence the official judgment in the disability process. When an instrument is stated to have complementary value for IPs in the assessment of physical work ability, it should reinforce their judgment and/or alter their judgment of the physical work ability. A majority of IPs did, indeed, indicate that the FCE information had reinforced their initial judgment. Also, a majority of IPs altered their initial assessment as only four IPs stuck by their original appraisal of all activities considered.

In addition, plasma cortisol concentrations (approximately 145–193 ng · dL−1) induced by the prolonged submaximal exercise in the study of Walker et al. buy Z-DEVD-FMK [35] are obviously lower than those in our study. Pre and post-intermittent exercise did not produce significantly different salivary cortisol concentrations after CHO beverage ingestion [59]. According to the results from the current investigation, adding CHO to a solution and

ingesting a CAF capsule does not affect hormone variables. This is probably because the intensity of the RSE exerts a strong influence on hormones without ergogenic aids. Changes in these hormones during RSE after ingesting CAF and CHO require further investigation. Conclusions The data demonstrate that ingesting CAF and CHO or only CAF does not increase peak or mean power, or total work during RSE, or improve selleck inhibitor agility, compared to ingesting PLA + PLA. In contrast to CAF + CHO, CAF + PLA, and PLA + PLA conditions, ingesting PLA + CHO increased sprint performance during 10 sets of 5 × 4-s sprints, with a 20-s rest interval between each sprint (2-min rest between each set). Ingesting PLA + CHO did not alter RPE, agility performance, or hormone profiles. The results suggest that in female athletes, ingesting CHO without CAF before exercise may increase

repeated sprint performance. Acknowledgements We would like to thank all participants and research assistants for their effort in the study. This work was partly supported by a research grant from the Ministry of Science and Technology, Taiwan (NSC 101–2410-H-110–085). This work was also particularly supported by “Aim for the Top University Plan” of National Taiwan Normal University , National Sun Yat-sen University, and the Ministry

of Education, Taiwan. References 1. Coutts AJ, Reaburn PR: Time and motion analysis of the AFL field umpire. Australian football league. J Sci Med Sport 2000, 3:132–139.PubMedCrossRef 2. Spencer M, Bishop D, Dawson B, Goodman C: Physiological and metabolic responses of repeated-sprint activities:specific to field-based team sports. Sports Med 2005, 35:1025–1044.PubMedCrossRef 3. Girard O, Mendez-Villanueva A, Bishop D: Repeated-sprint P-type ATPase ability – part I: factors contributing to fatigue. Sports Med 2011, 41:673–694.PubMedCrossRef 4. Gaitanos GC, Williams C, Boobis LH, Brooks S: Human MM-102 muscle metabolism during intermittent maximal exercise. J Appl Physiol 1993, 75:712–719.PubMed 5. Welsh RS, Davis JM, Burke JR, Williams HG: Carbohydrates and physical/mental performance during intermittent exercise to fatigue. Med Sci Sports Exerc 2002, 34:723–731.PubMedCrossRef 6. Davison GW, McClean C, Brown J, Madigan S, Gamble D, Trinick T, Duly E: The effects of ingesting a carbohydrate-electrolyte beverage 15 minutes prior to high-intensity exercise performance. Res Sports Med 2008, 16:155–166.PubMedCrossRef 7.

Wang M, Ahrné S, Jeppsson B, Molin G: Comparison of bacterial diversity along the human intestinal tract by

direct cloning and sequencing of 16S rRNA genes. FEMS Micro Ecol 2005, 54: 219–231.CrossRef 36. Lepage P, Seksik P, Sutren M, de la Cochetière MF, Jian R, Marteau P, Doré J: Biodiversity of the mucosa-associated microbiota is stable along the distal digestive tract in healthy individuals and patients with IBD. Inflamm Bowel Dis 2005, 11: 473–480.PubMedCrossRef 37. Green GL, Brostoff J, Hudspith B, Michael M, Mylonaki M, Rayment N, Staines N, Sanderson J, Rampton CRM1 inhibitor DS, Bruce KD: Molecular characterization of the bacteria adherent to human colorectal mucosa. J Appl Micro 2006, 100: 460–469.CrossRef 38. Schloss PD, Larget BR, Handelsman J: Integration of microbial ecology and statistics: a test to compare gene libraries. Appl Environ Microbiol 2004, 70: 5485–5492.PubMedCrossRef 39. Hamady M, Lozupone C, Knight R: Fast UniFrac: facilitating high-throughput phylogenetic analyses of microbial communities including analysis of pyrosequencing and PhyloChip

data. ISME J 2010, 4: 17–27.PubMedCrossRef 40. Schloss PD, Westcott TSA HDAC price SL, Ryabin T, Hall JR, Hartmann M, Hollister EB, Lesniewski RA, Oakley BB, Parks DH, Robinson CJ, Sahl JW, Stres B, Thallinger GG, Van Horn DJ, Weber CF: Introducing mothur: open-source, platform-independent, community-supported PXD101 supplier software for describing and comparing microbial communities. Appl Environ Microbiol 2009, 75: 7537–7541.PubMedCrossRef 41. Cole JR, Wang Q, Cardenas E, Fish J, Chai B, Farris RJ, Kulam-Syed-Mohideen AS, McGarrell DM, Marsh T, Garrity GM, Tiedje JM: The Ribosomal Database Project: improved alignments and new tools for rRNA analysis. Nucleic Acids Res 2009, (37 Database) : D141–145. 42. Sokol H, Pigneur B, Watterlot L, Lakhdari O, Bermúdez-Humarán LG, Gratadoux JJ, Blugeon S, Bridonneau C, Furet JP, Corthier G, Grangette C, Vasquez N, Pochart P, Trugnan G, Thomas G, Blottière HM, Doré J, Marteau P, Seksik P, Langella P: Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified Tenofovir purchase by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci USA 2008, 105: 16731–16736.PubMedCrossRef

43. Eckburg PB, Relman DA: The role of microbes in Crohn’s disease. Clin Infect Dis 2007, 44: 256–262.PubMedCrossRef 44. Loubinoux J, Bronowicki J, Pereira IAC, Mougenel J, Le Faou AE: Sulfate-reducing bacteria in human feces and their association with inflammatory bowel diseases. FEMS Micro Ecol 2002, 40: 107–112.CrossRef 45. Seksik P, Rigottier-Gois L, Gramet G, Sutren M, Pochart P, Marteau P, Jian R, Doré J: Alterations of the dominant faecal bacterial groups in patients with Crohn’s disease of the colon. Gut 2003, 52: 237–242.PubMedCrossRef 46. Mangin I, Bonnet R, Seksik P, Rigottier-Gois L, Sutren M, Bouhnik Y, Neut C, Collins MD, Colombel JF, Marteau P, Doré J: Molecular inventory of faecal microflora in patients with Crohn’s disease. FEMS Micro Ecol 2004, 50: 25–36.

6a, g). Bryophytes (mainly mosses) dominate at the Gössenheim, Öland and Tabernas sites, with Gössenheim having the highest moss coverage of more than 40 % (Fig. 3a). At these three

sites, cyanolichen coverage is well below 5 % and the amount of the bare soil fraction is highest at the Swedish Öland site, followed XMU-MP-1 by the Tabernas site (Fig. 6a). Fig. 3 a Coverage of the different crust types and other vegetation at all sites; b chlorophyll content (a and a + b; lines in bars show standard deviation) at all sites C59 wnt manufacturer Biological soil crust chlorophyll a and chlorophyll a + b content reached values around 200 mg chlorophyll a + b per m2 at

all sites with slightly higher values at the human influenced sites Öland and Gössenheim (Fig. 3b). This places the four SCIN-BSC sites at the lower end of the soil crust chlorophyll a + b content scale, ranging from 980 mg/m2 in the local steppe formation near Würzburg, Germany to 500 mg/m2 in the Namib Desert, Namibia and down to 380 mg/m2 in Utah, USA (Lange 2003). However, the SCIN-BSC values are comparable to those of the BSCs found along the BIOTA-South transect in South Africa and Namibia (Büdel et al. 2009). Soil properties and structure Soil types at the Öland site are skeletal and Rendzic Leptosols with a depth of less than 20 cm and Ai, (B), BC, and C horizons. The bedrock is find more an Ordovician limestone with “alvarmo layers” (cromic, relic?). Soil pH is 7.35 ± 0.05 (n = 40), while the pH of the BSC

is 7.3 ± 0.06 (n = 40). At the Gössenheim site, soil types are skeletal, Rendzic Leptosols with a depth of less than 10 cm and AC and C horizons. The bedrock is a Triassic shell limestone (Muschelkalk) with characteristic top soil removal. Soil pH is 7.37 ± 0.06 (n = 40), while the pH of the BSC is 7.33 ± 0.07 (n = 40). Soil types at the Hochtor site are calcareous Regosols and Rendzic Leptosols with a depth of 15–30 (>50) cm and A1, A2, C1, and C2 horizons, with a buried iron-humus layer. The bedrock is Triassic Seidlwinkl and Rauwacke. Soil pH is 7.43 ± 0.09 (n = 40), while Pyruvate dehydrogenase the pH of the BSC is 7.34 ± 0.05 (n = 40). Soil types at the Tabernas site are Haplic Calcisols with a depth of less than 100 cm and A, AC, Ck1, Ck2, and C3 horizons, originating from Miocene sediments (gypsum-calcitic mudstone and sandstones) with a surface accumulation of gypsum. Soil pH is 7.4 ± 0.06 (n = 40), while the pH of the BSC is 7.03 ± 0.1 (n = 40). Soil compaction was highest (3.84 ± 0.1 kg/cm2) and clay content lowest (<3 %) at the Hochtor site (Fig. 4a–b) which also had the highest water holding capacity, 48.1 ± 5.

melanogaster Dm +; D. simulans Ds + and Ds -. B = blank. Note: IS5 primer set does not produce amplicons in all three Glossina samples due to complete absence of this IS element in symbionts of tsetse flies (see discussion). mTOR inhibitor We have recently shown that Wolbachia titers increase in D. paulistorum[11] and Glossina[12] hybrid backgrounds, which should significantly facilitate detection and strain characterization. Such titer increase was sufficient to

detect Wolbachia with the IS5 primer set in A/O hybrids, but the low-titer Wolbachia infection in the AM mother still remained undetected (Figure 2B). Failure of IS5-amplification in the Gs/Gm hybrid plus parents is explained by lacking homology between primer sequences and target, as no matches with the IS5 primer

sequence were found in the wGmm genome [14]. This finding implies that TNF-alpha inhibitor IS5 is not suitable as a general Wolbachia A-supergroup marker. Figure 2A and B show that the ARM-marker system can be applied to address aforementioned problems arising with wsp and IS5 primer: sensitivity during PCR is increased significantly and all tested A-supergroup infections are unambiguously detected. Wolbachia was traced in all low-titer New world Drosophila species (AM1, AM2; CA1, CA2) plus the A/O hybrid. In contrast to IS5, the ARM primer set amplified Wolbachia from all three Glossina samples (Gmm, Gsw and Gs/Gm hybrid). As anticipated, all samples from high-titer Wolbachia infections (OR, Dw + , Dm +, Ds +) showed bright bands with ARM, whereas Wolbachia-uninfected specimens (Dw -, Ds -) did not (Figure 2A,B). This argues for a high specificity of the ARM primer and against mis-amplification of a random Unoprostone host target

rather than the specific symbiont target site. Conclusions We suggest that the new multicopy Wolbachia A-supergroup marker can be used as an ‘ultra-sensitive’ tool to trace low-titer infections by means of classic end-point PCR. First, ARM has the advantage of higher sensitivity compared to classic singlecopy Wolbachia markers like wsp and thus improves detection limit significantly. Particularly, ARM-PCR can be easily applied to screen larger numbers of untyped DNA specimens, even of low quality arising from long-term storage and/or storage in inappropriate media, from laboratory stocks or samples directly from nature. This is of pivotal interest since classical detection tools might yield false negatives when examining species harboring Wolbachia at very low densities, and thereby lead to underestimating natural prevalence of A-supergroup infections. Given that 80% of the Dipteran infections are supergroup A [15], our new method will significantly facilitate and improve the sensitivity of such surveys. In AZD5582 addition our approach is an advantage over the classic IS5-marker, which fails in Wolbachia from the tsetse fly Glossina.

PFGE typing was undertaken at the Moredun Research Institute, Scotland, UK and VISAVET, Madrid, Spain. IS900-RFLP typing 4SC-202 chemical structure was carried out at the Veterinary Research Institute in Brno, Czech Republic and VISAVET. Published standardized typing procedures were used as described in Materials and Methods. The only difference

in procedures between laboratories was that at 3-Methyladenine solubility dmso VISAVET the IS900-RFLP analysis was performed using the agarose plugs prepared for PFGE to avoid having to perform two separate DNA preparations for the different typing techniques. The correct profiles were reported by all laboratories for the duplicate isolates included to check reproducibility. All typing techniques correctly reported that the Mycobacterium phlei (M. phlei), Mycobacterium bovis BCG (M. bovis BCG) and IS901 positive M. avium were not Map. One field isolate, EU112 was found to be IS901 positive M. avium (it SB-715992 is not known if the isolate is M. avium subsp. avium or M. avium subsp. silvaticum) and not Map as was originally suspected. Another isolate, EU169 was

found to be a mixed culture. Isolates one to 50 were typed at Institut für Mikrobiologie Stiftung Tierärztliche Hochschule Hannover, Hannover, Germany using the Type I/Type II PCR as described by Dohmann et al. [17]. EU25 and EU30 were identified as Type I and all other field isolates as Type II. These results correlated with the strain type as determined click here by PFGE. This PCR [17] cannot

discriminate between Type I and Type III and as strain types could be discerned from the PFGE profiles, it was not considered necessary to determine the strain type of the remaining isolates by PCR. It was not possible to type all of the isolates with all typing methods as some laboratories had difficulties in subculturing some isolates to prepare sufficient cells for analyses. A total of 123 Map isolates were typed by IS900-RFLP, PFGE and MIRU-VNTR. IS900-RFLP typing IS900-RFLP typing data were obtained for 147 Map isolates (Table 1 and see supplementary dataset in Additional file 1). It was not possible to obtain PstI profiles for 55 isolates or clear BstEII profiles for five isolates. There was a problem using agarose plug DNA for IS900-RFLP typing with PstI as the enzyme would not cleave in the presence of agarose. Extraction of the DNA from the agarose and repeat PstI digestion was not attempted. As expected, profiles were not obtained for the negative control strains M. bovis BCG, M. phlei and IS901 positive M. avium. A total of six PstI profiles were found among 93 isolates: B (n = 88); G (n = 1); I (n = 1); K (n = 1); R (n = 1); and U (n = 1). Seventeen BstEII profiles were detected among 142 isolates: C1 (n = 71); C17 (n = 49); C5 (n = 5); C9 (n = 3); C16 (n = 2) and single isolates with C10, C18, C22, C27, C29, C35, C36, C38, C39, S4, I4 and I5.

Indicator strains included E. coli FUA1036, E. coli FUA1063, E. coli FUA1064, Selleck IACS-010759 Listeria innocua ATCC33090, and Enterococcus facaelis FUA3141. The deferred inhibition assay was repeated with the addition of 20 g L-1 proteinase K in 100 mmol L-1 Tris-Cl, pH 8.5, which was spotted adjacent to test strain colonies and plates were incubated for four hours at 55°C to maximize proteinase activity before overlayering was conducted. Identification of library clones via sequencing PCR-DGGE analysis was initially carried out characterise bovine vaginal microbiota by a culture-independent approach. The DNA concentration of samples from healthy cows, however, was below the detection limit of PCR-DGGE

analysis and DGGE patterns could be obtained only for two samples from animals #2373 #2409 (data not shown). Total bacterial DNA was isolated from

these two vaginal swab samples via both phenol see more chloroform extraction and Wizard MagneSil® Tfx™ System (Promega). Nested PCR was conducted to maximize DNA amplification by amplifying with 616V and Captisol datasheet 630R primers prior to amplification with HDA primers (Table 2). PCR products that were amplified with HDA primers were cloned into a pCR 2.1-TOPO vector using the TOPO TA Cloning® Kit (Invitrogen) according to manufacturer’s instructions. The Promega’s Wizard® Plus SV A clone library was constructed using PCR products that were amplified with HDA primers, which were then cloned into a pCR 2.1-TOPO vector, using the TOPO TA Cloning® Kit (Invitrogen) according to manufacturer’s instructions. The Promega’s Wizard® Plus SV Minipreps DNA Purification System was used for plasmid isolation. To confirm the cloning of the inserts, sequencing of the amplified insert was performed according to the Invitrogen TOPO TA Cloning® Kit manual. Quantitative PCR Quantitative PCR was conducted with vaginal mucus samples collected from ten cows, using syringes fitted with an approximately 30 cm long collection tube. Samples from 10 animals that developed metritis Interleukin-3 receptor after calving were randomly selected from samples of a larger cohort of animals. Total

bacterial DNA was extracted using the Wizard MagneSil® Tfx™ System (Promega) and DNA concentrations were measured using the NanoDrop spectrophotometer system ND-1000, software version 3.3.0 (Thermo Fisher Scientific Inc., Wilmington, USA). All dagger-marked primer pairs that are listed in Table 2 were used in the preparation of standards and qPCR analyses. Standards were prepared using purified PCR products, which were serially diluted ten-fold. Diluted standards (10-3 to 10-8) were used to generate standard curves. TaqMan probes were used for the pedA gene and the total bacteria qPCR experiments. In both cases, each probe was labelled with 5’-FAM and 3’-TAMRA as fluorescent reporter dye and quencher respectively. The total reaction volume was set to 25 μL, which contained 12.5 μL TaqMan Universal PCR Master Mix (Applied Biosystems), 2.

Eur J Gynaecol Oncol. 2006;27(6):621-2 1 2007 Saad S and col. Benign peritoneal multicystic mesothelioma diagnosed and treated by laparoscopic surgery. J Laparoendosc Adv Surg Tech A. 2007 Oct;17(5):649-52 1 2008 Ashqar S and col.

Benign mesothelioma of peritoneum presenting as a pelvic mass.J Coll Physicians Surg Pak. 2008 Nov;18(11):723-5 1 2008 Chammakhi-Jemli C and col. Benign Z-DEVD-FMK concentration cystic mesothelioma of the peritoneum. Tunis Med. 2008 Jun;86(6):626-8 1 2008 Stroescu and col. Recurrent benign cystic peritoneal mesothelioma. Chirurgia (Bucur). 2008 Nov-Dec;103(6):715-8 1 2009 Uzum N and col. Benign multicystic peritoneal mesothelioma.Turk J Gastroenterol. 2009 Jun;20(2):138-41 1 2010 Limone A and col. Laparoscopic excision of a benign peritoneal cystic mesothelioma. Arch Gynecol Obstet. 2010 Mar;281(3):577-8 1 2010 Pitta X and col. Benign multicystic peritoneal mesothelioma: a case report. J Med Case Rep. 2010 Nov 29;4:385 1 2011 Akbayir O and col. Benign cystic mesothelioma: a case series with one case complicated check details by pregnancy. J Obstet Gynaecol Res.

2011 Aug;37(8):mTOR phosphorylation 1126-31. 3 2012 Lari F and col. Benign multicystic peritoneal mesothelioma. A case report. Recenti Prog Med. 2012 Feb;103(2):66-8 1 2012 Stojsic Z and col. Benign cystic mesothelioma of the peritoneum in a male child.J Pediatr Surg. 2012 Oct;47(10):e45-9 1 2012 Khuri S and col. Benign cystic mesothelioma of the peritoneum: a rare case and review of the literature. Case Rep Oncol. 2012 Sep;5(3):667-70. 1 2013 Singh A and col. Multicystic peritoneal mesothelioma: not always a benign disease.Singapore Med J. 2013 Apr;54(4):e76-8 1 Conclusion Benign cystic mesothelioma of the peritoneum (BCM) is a rare tumor with a high local recurrence

rate. It requires optimal care in a specialized center especially as there is no evidence-based treatment strategies. Consent Written informed consent was obtained from the patient for publication of this Case report and any accompanying images. References 1. Mennemeyer R, Smith M: Multicystic, peritoneal mesothelioma: a report with electron microscopy of a case mimicking intra-abdominal cystic hygroma (lymphangioma). Cancer 1979, 44:692–698.PubMedCrossRef 2. Safioleas Exoribonuclease MC, Constantinos K, Michael S, Konstantinos G, Constantinos S, Alkiviadis K: Benign multicystic peritoneal mesothelioma: a case report and review of the literature. World J Gastroenterol 2006,12(35):5739–5742.PubMed 3. González-Moreno S, Yan H, Alcorn KW, Sugarbaker PH: Malignant transformation of “”benign”" cystic mesothelioma of the peritoneum. J Surg Oncol 2002, 79:243–251.PubMedCrossRef 4. Van Ruth S, Bronkhorst MWGA, Van Coeverden F, et al.: Peritoneal benign cystic mesothelioma: a case report and review of literature. Eur J Surg Oncol 2002, 28:192–195.PubMedCrossRef 5. Bhandarkar DS, Smith VJ, Evans DA, Taylor TV: Benign cystic peritoneal mesothelioma. J Clin Pathol 1993, 46:867–868.PubMedCrossRef 6.

Clin Infect Dis 2010,1(50):40–48.CrossRef 4. García-Fernández A, Fortini D, Veldman K, Mevius D, Carattoli A: Characterization of plasmids harbouring qnrS1 , qnrB2 and qnrB19 genes in Salmonella. J Antimicrob Chemother 2009,63(2):274–281.selleck chemicals PubMedCrossRef 5. Carattoli A, Bertinia A, Villa L, Falbo V, Hopkins KL, Threlfall EJ: Identification of plasmids by PCR-based replicon typing. J Microbiol Methods 2005,63(3):219–228.PubMedCrossRef 6. Garcillán-Barcia MP, Francia MV, de la Cruz F: The diversity of conjugative

relaxases and its application in plasmid classification. FEMS Microbiol Rev 2009,33(3):657–687.PubMedCrossRef 7. Carattoli A: Resistance plasmid families in Enterobacteriaceae. Antimicrob Agents Chemother 2009, click here 53:2227–2238.PubMedCrossRef 8. Novais A, Canton R, Valverde A, Machado

E, Galan JC, Peixe L, Carattoli A, Baquero F, Coque TM: Dissemination and Persistence of blaCTX-M-9 Are Linked to Class 1 Integrons Containing CR1 Associated with Defective Transposon derivatives from Tn402 Located in Early Antibiotic Resistance Plasmids of IncHI2, IncP1, and IncFI Groups. Antimicrob Agents Chemother 2006,50(8):2741–2750.PubMedCrossRef 9. Hopkins KL, Liebana E, Villa L, Batchelor M, Threlfall EJ, Carattoli A: Replicon typing of plasmids carrying CTX-M or CMY beta-lactamases circulating among Salmonella and Escherichia coli isolates. Antimicrob check details Agents Chemother 2006,50(9):3203–3206.PubMedCrossRef 10. Woodford N, Carattoli A, Karisik E, Underwood A, Ellington MJ, Livermore DM: Complete nucleotide sequences of plasmids pEK204, pEK499, and pEK516, encoding CTX-M enzymes in three major Escherichia coli lineages from the United Kingdom, all belonging to the international O25:H4-ST131 clone. Antimicrob

Agents Chemother 2009,53(10):4472–4482.PubMedCrossRef 11. Gołebiewski M, Kern-Zdanowicz I, Zienkiewicz M, Adamczyk M, Zylinska J, Baraniak A, Gniadkowski M, Bardowski J, Cegłowski P: Complete nucleotide sequence of the pCTX-M3 plasmid and its involvement Obatoclax Mesylate (GX15-070) in spread of the extended-spectrum beta-lactamase gene blaCTX-M-3. Antimicrob Agents Chemother 2007,51(11):3789–3795.PubMedCrossRef 12. Jungmin Kim Y-ML, Jeong Y-S, Seol S-Y: Occurrence of CTX-M-3, CTX-M-15, CTX-M-14, and CTX-M-9 Extended-Spectrum beta-Lactamases in Enterobacteriaceae Clinical Isolates in Korea. Antimicrob Agents Chemother 2005,49(4):1572–1575.PubMedCrossRef 13. TM Coque AN, Carattoli A, Poirel L, Pitout J, Peixe L, Baquero F, Cantón R, Nordmann P: Dissemination of clonally related Escherichia coli strains expressing extended-spectrum β-lactamase CTX-M-15. Emerg Infect Dis 2008,14(2):195–200.CrossRef 14.

Evol Appl 3:538–546CrossRef Gundel PE, Zabalgogeazcoa I, Vázquez de Aldana BR (2011)

Interaction between plant genotype and the symbiosis with Epichloë fungal endophytes in seeds of red fescue (Festuca rubra). Crop For Sci 62:1010–1016 Gundel PE, Garibaldi LA, Martínez-Ghersa MA, Ghersa CM (2012) Trade-off between seed number and weight: influence of a grass-endophyte symbiosis. Basic Appl Ecol 13:32–39CrossRef Hahn HM, McManus T, Warnstorff K, Monahan BJ, Young CA, Davies E, Tapper BA, Scott B (2008) Neotyphodium fungal endophytes confer physiological protection to perennial ryegrass (Lolium perenne L.) subjected to a water deficit. Environ Exp Bot 63:183–199CrossRef Hamilton CE, Bauerle, TL (2012) A new currency for mutualism: Neotyphodium antioxidants and host drought response. Fungal Divers Hamilton CE, Faeth SH, Dowling TE (2009) Distribution QNZ of hybrid fungal symbionts and environmental stress. Microbial Ecol 58:408–413CrossRef Hamilton CE, Dowling TE, Faeth SH (2010) Hybridization in endophyte symbionts alters host response to moisture and nutrient treatments. Microb Ecol 59:768–75PubMedCrossRef Harman GE (2000) Myths and dogmas of biocontrol: changes in perceptions derived from research on Trichoderma harzianum T-22. Plant Dis 84:377–393CrossRef

Harman GE (2006) Overview of mechanisms and uses of Trichoderma 2-hydroxyphytanoyl-CoA lyase spp. Phytopathology 96:190–194PubMedCrossRef Harman GE (2011) Multifunctional fungal plant symbionts: new tools to enhance HDAC inhibitor review plant growth and productivity. New Phytol 189:647–649PubMedCrossRef

Harman GE, Howell CR, Viterbo A, Chet I, Lorito M (2004) Trichoderma species – opportunistic, avirulent plant symbionts. Nat Rev find more Microbiol 2:43–56PubMedCrossRef Hesse U, Schöberlein W, Wittenmayer L, Förster K, Warnstorff K, Diepenbrock W, Merbach W (2003) Effects of Neotyphodium endophytes on growth, reproduction and drought-stress tolerance of three Lolium perenne L. genotypes. Grass Forage Sci 58:407–415CrossRef Hoque A, Banu NA, Okuma E, Amako K, Nakamura Y, Shimoishi Y, Murata Y (2007) Exogenous proline and glycinebetaine increase NaCl-induced ascorbate-glutathione cycle enzyme activities, and proline improves salt tolerance more than glycinebetaine in tobacco Bright Yellow-2 suspension-cultured cells. J Plant Phys 164:1457–68CrossRef Huang W-Y, Cai Y-Z, Xing J, Corke H, Sun M (2007) A Potential antioxidant resource: endophytic fungi from medicinal plants. Econ Bot 61:14–30CrossRef Jaspers P, Kangasjärvi J (2010) Reactive oxygen species in abiotic stress signaling. Physiol Plantarum 138:405–13CrossRef Jennings DB, Ehrenshaft M, Pharr DM, Williamson JD (1998) Roles for mannitol and mannitol dehydrogenase in active oxygen-mediated plant defense.